Clinical trial
Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome…
NCT00455767 · Debiopharm International SA, Industry · Completed
Key facts
| NCT number | NCT00455767 |
|---|---|
| Title | Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients |
| Official title | Phase IIA Multicenter 1 Week Treatment, Randomised, Double-Blind, Placebo Controlled Study of Depelestat in Patients Suffering From Acute Respiratory Distress Syndrome |
| Lead sponsor | Debiopharm International SA, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibrosis, Lung Disease, Respiratory Disorders, Respiratory Distress Syndrome, Adult, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis, Inflammation |
| Intervention type | Drug |
| Interventions | EPI-hNE4, Placebo |
| Enrollment | 84 |
| Start date | Jul 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 4, 2007 |
| Last update posted | Jun 24, 2008 |
| Countries | France, Italy, Spain, Tunisia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: